Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
2015 Nobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Cancer Statistics, 2021
2021 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Molecular biology and genetics of prion diseases
1994 StandoutNobel
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
2000 Standout
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Heterogeneity of hepatitis delta antigen
1990
Natural history of hepatitis B
2003
Comparative analysis of scrapie agent inactivation methods
1993
Molecular pathogenesis of neurotropic viral infections
1987
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
2016
Kaposi's sarcoma
1993
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection☆
2004
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
2006
Treatment of Chronic Hepatitis D with Interferon Alfa-2a
1994
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
2000
Hepatitis B virus infection
2009 Standout
Severe Sepsis and Septic Shock
2013 Standout
The long‐term effect of treatment with interferon‐α2a in chronic hepatitis B
1998
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Hepatitis B vaccines
2003
Prion Protein Isoforms, a Convergence of Biological and Structural Investigations
1995 StandoutNobel
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B
2002
Reappearance of Hepatitis D Virus (HDV) Replication in Chronic Hepatitis B Virus Carrier Chimpanzees Rechallenged with HDV
1989
The Double-stranded RNA-activated Kinase, PKR, Can Phosphorylate Hepatitis D Virus Small Delta Antigen at Functional Serine and Threonine Residues
2002
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Skin Hygiene and Infection Prevention: More of the Same or Different Approaches?
1999 Standout
Treating hepatitis C
2005 StandoutNobel
Immunologic and Molecular Biologic Studies of Prion Proteins in Bovine Spongiform Encephalopathy
1993 StandoutNobel
The long and winding road leading to the identification of the hepatitis C virus
2009 StandoutNobel
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Human prion diseases
1994 StandoutNobel
Creutzfeldt-Jakob Disease in a Pregnant Woman with an Implanted Dura Mater Graft
1994
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Creutzfeldt-Jakob Disease: Recommendations for Disinfection and Sterilization
2001
Long-term benefit of interferon α therapy of chronic hepatitis D: regression of advanced hepatic fibrosis
2004
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease
1994 Nobel
Increased Incidence of Fulminant Hepatic Failure in Previously Unrecognized HBsAg Carriers with Acute Hepatitis Independent of Etiology
2005
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Herpes Zoster
2013 Standout
Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers
1997
Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein
1995 StandoutNobel
Clinical Aspects of the Interactions Between Human Immunodeficiency Virus and the Hepatotropic Viruses
1994
Prednisone-interferon combination in the treatment of chronic hepatitis B: Direct and indirect metanalysis
1994
Interferon-inducible antiviral effectors
2008 Standout
The use of antiviral agents for the management of severe influenza
2010
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta
1988 StandoutNobel
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis δ Antigen
1998 StandoutNobel
Transperitoneal versus retroperitoneal approach for aortic reconstruction: A randomized prospective study
1990
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.
1984
Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis.
1983
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors.
1988
Structure, sequence and expression of the hepatitis delta (δ) viral genome
1986 StandoutNatureNobel
Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft
1988
TREATMENT OF CHRONIC HEPATITIS DUE TO HEPATITIS B VIRUS
1985
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
The Delta Agent
1983
Screening for Hepatitis C Virus Infection in Adolescents and Adults
2020
Prion Diseases and the BSE Crisis
1997 StandoutScienceNobel
Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody-positive patients
1987
Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s
1998 Standout
A Single Nucleotide Change in the 5′ Noncoding Region of Sindbis Virus Confers Neurovirulence in Rats
1999 StandoutNobel
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Prions
1998 StandoutNobel
Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D
1991
Epidemiology and Clinical Impact of Hepatitis D Virus (Delta) Infection
1985
Possible Viral Interactions in the Acquired Immunodeficiency Syndrome (AIDS)
1984
Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie.
1994 StandoutNobel
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.
1994 StandoutNobel
Viral Hepatitis in Colombia: A Study of the “Hepatitis of the Sierra Nevada De Santa Marta”
1985
Fulminant B Viral Hepatitis: Role of Delta Agent
1984
Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection
1987 StandoutNobel
Interferon-α for HBeAg-positive chronic hepatitis B
2003
Delta hepatitis — Present status
1985
Prion diseases of humans and animals
1996 StandoutNobel
Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred.
1992 StandoutNobel
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel
Genetic determinants of Sindbis virus neuroinvasiveness
1997 StandoutNobel
Works of F. Caredda being referenced
Serological response to the hepatitis dSerological response to the hepatitis delta virus in hepatitis D.
1987
Incidence of Hepatitis Delta Virus Infection in Acute HBsAg-Negative Hepatitis
1989
Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study
1990
Rapidly progressive HBsAg-positive hepatitis in Italy
1987
Prospective study of epidemic delta infection in drug addicts.
1983
INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B
1982
CLINICAL SIGNIFICANCE OF ANTIBODY TO THE HEPATITIS DELTA VIRUS IN SYMPTOMLESS HBsAg CARRIERS
1985
Hepatitis B Virus-Associated Coinfection and Superinfection with Agent: Indistinguishable Disease with Different Outcome
1985
Course and prognosis of acute HDV hepatitis.
1987